Get Live Data

Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Firering Strategic Minerals : from explorer to producer
Firering Strategic Minerals: From explorer to producerView Video

Latest Share Chat

  2. Share Prices
  3. Syncona Share Price
  4. Syncona Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksSyncona Share News (SYNC)

Syncona Information

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.80
Bid: 112.80
Ask: 113.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.177%)
Open: 111.20
High: 114.00
Low: 111.20
Prev. Close: 112.80
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 09th Nov 2023 15:44

Friday 10 November 
Allianz Technology Trust PLCQ3 Results
Wheaton Precious Metals CorpQ3 Results
Monday 13 November 
Bank of Cyprus Holdings PLCQ3 Results
British Land Co PLCHalf Year Results
Kainos Group PLCHalf Year Results
Team Internet Group PLCQ3 Results
Tuesday 14 November 
ActiveOps PLCHalf Year Results
Babcock International Group PLCHalf Year Results
Bank of Georgia Group PLCQ3 Results
Castings PLCHalf Year Results
ConvaTec Group PLCTrading Statement
DCC PLCHalf Year Results
Forterra PLCHalf Year Results
Gear4Music PLCHalf Year Results
Genel Energy PLCTrading Statement
HydrogenOne Capital Growth PLCQ3 Results
Hill & Smith PLCTrading Statement
Imperial Brands PLCFull Year Results
Informa PLCTrading Statement
Land Securities Group PLCHalf Year Results
Oxford Instruments PLCHalf Year Results
Picton Property Income LtdHalf Year Results
Renalytix PLCQ1 Results
Vesuvius PLCTrading Statement
Vodafone Group PLCHalf Year Results
Wise PLCHalf Year Results
Wednesday 15 November 
Diversified Energy Co PLCTrading Statement
Experian PLCHalf Year Results
Fuller, Smith & Turner PLCHalf Year Results
Genuit Group PLCTrading Statement
Intermediate Capital Group PLCHalf Year Results
Ninety One PLC and LtdHalf Year Results
Renold PLCHalf Year Results
SSE PLCHalf Year Results
Synthomer PLCTrading Statement
Tracsis PLCFull Year Results
Tullow Oil PLCTrading Statement
Warehouse REIT PLCHalf Year Results
Thursday 16 November 
Assura PLCHalf Year Results
Atalaya Mining PLCQ3 Results
Aviva PLCTrading Statement
Burberry Group PLCHalf Year Results
Close Brothers Group PLCTrading Statement
CMC Markets PLCHalf Year Results
Crest Nicholson Holdings PLCTrading Statement
Halma PLCHalf Year Results
Great Portland Estates PLCHalf Year Results
Kier Group PLCTrading Statement
International Distributions Services PLCHalf Year Results
Investec PLC and LtdHalf Year Results
Liontrust Asset Management PLCHalf Year Results
Manolete Partners PLCHalf Year Results
Melrose Industries PLCTrading Statement
Norcros PLCHalf Year Results
Premier Foods PLCHalf Year Results
Qinetiq Group PLCHalf Year Results
Spirax-Sarco Engineering PLCTrading Statement
Syncona LtdHalf Year Results
Tatton Asset Management PLCHalf Year Results
Tyman PLCTrading Statement
United Utlities Group PLCHalf Year Results
Young & Co's Brewery PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
7 Aug 2020 08:17

Syncona portfolio company Freeline prices US IPO

(Sharecast News) - Healthcare investment company Syncona announced on Friday that its portfolio company Freeline Therapeutics has priced its initial public offering in the United States.

Read more
3 Aug 2020 22:16

UK TRADING UPDATE SUMMARY: Bluebird To Buy Southern Gold Venture Stake

UK TRADING UPDATE SUMMARY: Bluebird To Buy Southern Gold Venture Stake

Read more
20 Jul 2020 08:44

Syncona Investee Freeline Therapeutics Files For Possible US Listing

Syncona Investee Freeline Therapeutics Files For Possible US Listing

Read more
20 Jul 2020 07:22

Syncona's Freeline files IPO registration document

(Sharecast News) - Healthcare investor Syncona said its portfolio company Freeline Therapeutics has filed a registration statement with the US Securities and Exchange Commission for a proposed initial public offering (IPO).

Read more
13 Jul 2020 18:36

Syncona's Investee Freeline Publishes Further Data For FLT180a

Syncona's Investee Freeline Publishes Further Data For FLT180a

Read more
30 Jun 2020 10:33

Syncona Investee Freeline Raises USD120 Million And Mulls US Listing

Syncona Investee Freeline Raises USD120 Million And Mulls US Listing

Read more
30 Jun 2020 08:26

Syncona revalues holding in Freeline after expanded series C

(Sharecast News) - Healthcare investment and development company Syncona announced on Tuesday that Freeline Therapeutics - a biotechnology company focussed on developing curative gene therapies for chronic systemic diseases - has raised a further $80m (£65.09m) from specialist global institutional investors in an expanded series C round.

Read more
18 Jun 2020 16:40

DIRECTOR DEALINGS: Syncona Non-Exec Reverberi Buys GBP50,000 In Shares

DIRECTOR DEALINGS: Syncona Non-Exec Reverberi Buys GBP50,000 In Shares

Read more
15 Jun 2020 09:19

Former Bayer Healthcare Chief Medical Officer Malik Joins Syncona

Former Bayer Healthcare Chief Medical Officer Malik Joins Syncona

Read more
11 Jun 2020 09:26

Syncona Annual Assets Take Hit From Autolus Value But Likes Portfolio

Syncona Annual Assets Take Hit From Autolus Value But Likes Portfolio

Read more
11 Jun 2020 08:32

Syncona asset values fall after Autolus shares plunge

(Sharecast News) - Syncona reported a 13% fall in net asset value as the value of its life sciences division dropped by a quarter in its most recent financial year.

Read more
4 Jun 2020 18:21

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
29 May 2020 09:07

Syncona Investee Achilles Therapeutics Starts Melanoma Therapy Trial

Syncona Investee Achilles Therapeutics Starts Melanoma Therapy Trial

Read more
29 May 2020 08:12

Syncona portfolio firm Achilles doses first patient in T cell therapy trial

(Sharecast News) - Syncona announced on Friday that its portfolio company, Achilles Therapeutics, has dosed the first patient in a phase 1 and 2 clinical study of its clonal neoantigen T cell (cNeT) therapy, in patients with recurrent or metastatic malignant melanoma.

Read more
23 Apr 2020 11:01

Syncona Makes USD51 Million Investment Into SwanBio Therapeutics

Syncona Makes USD51 Million Investment Into SwanBio Therapeutics

Read more
789101112131415

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.